Latest News from Dexela

 [archive]
Dexela to exhibit at RSNA 2008 (05 November 2008)
Dexela will be exhibiting on the NDS Surgical Imaging booth 4029 in the south building at this years RSNA in Chicago.
Dexela fund raising of £2.6 Million (17 July 2008)
Dexela Limited, the London-based company developing accurate and sensitive 3D imaging technology known as Tomosynthesis, focused initially on the early detection of breast cancer, is pleased to announce...
Dexela appoints Peter Denyer as Director and Non-Executive Chairman (01 July 2008)
Dexela Limited (‘Dexela’ or ‘the Company’) Appointment of Chairman Dexela Limited is pleased to announce the appointment of Peter Denyer as Director and Non-Executive Chairman of Dexela Limited. Dexela’s...
Dexela wins International Trade Award (30 June 2008)
Dexela has beaten off four other finalists to win the International Innovation category at the 2008 London Passport to Export Awards, the capital’s premier international business awards scheme. The...
Dexela exhibits DexTop, its state of the art 3D mammography workstation, at the DRK conference in Berlin, 30 April – 3 May 2008 (02 May 2008)
Dexela, a technology leader in the development of 3D medical imaging, will be exhibiting DexTop, its state of the art 3D mammography workstation at the DRK conference in Berlin. The annual radiology event...



Dexela at RSNA 2008
Dexela will be exhibiting on the NDS Surgical Imaging booth 4029 in the south building at this years RSNA in Chicago.


Dexela fund raising of £2.6 Million
Dexela Limited is pleased to announce that it has raised more than £2.6 million through the issue of shares. The main investors in this funding round included Close Ventures and London Technology Fund.


Dexela gains ISO certification
Dexela has achieved ISO 13485 and ISO 9001 certification for its quality management system. The quality management system has been certified by Lloyd’s Register Quality Assurance Limited. The accredited certification body has verified that the organization and all the functions of Dexela fulfil the requirements stated in the standards ISO 9001 and ISO 13485.


Dexela extends strategic partnership with XCounter
Dexela has deepened its strategic relationship with XCounter AB, the developer of the innovative XC Mammo -3T scanner and other 3D X-ray technologies.


   © Dexela Limited 2008 Registered Company 04797594